COVID-19 Pandemisinin Meme Kanseri Tarama ve Tanı Sürecine Etkisi

Author:

BÜLBÜL Hande Melike1ORCID,HÜRSOY Nur1ORCID,TAŞÇI Filiz1ORCID,BEDİR Recep2ORCID,BÜLBÜL Ogün3ORCID,AYDIN Esra4ORCID,PERGEL Ahmet5ORCID

Affiliation:

1. RECEP TAYYIP ERDOGAN UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, RADIOLOGY SCIENCE MAJOR

2. RECEP TAYYIP ERDOGAN UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, DEPARTMENT OF MEDICAL PATHOLOGY

3. RECEP TAYYIP ERDOGAN UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF NUCLEAR MEDICINE

4. RECEP TAYYIP ERDOGAN UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, MEDICAL ONCOLOGY

5. RECEP TAYYIP ERDOGAN UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, DEPARTMENT OF GENERAL SURGERY

Abstract

Aim: The COVID-19 pandemic has caused delays in breast cancer screening and diagnostic procedures. The aim of this research was to compare the status of breast cancer screenings and newly diagnosed breast cancer cases during the pandemic compared to the pre-pandemic period. Material and method: This retrospective study included patients with screening mammography, imaging-guided biopsies, and newly diagnosed breast cancer from March 2020– February 2021 (during-COVID-19) were compared with March 2019–February 2020 (pre-COVID-19). We compared numbers and distribution over time of mammography and biopsies between the time periods. In the breast cancer group; the stage at diagnosis and histopathological features of the tumor were also compared. Results: Compared to pre-pandemic mammography scans, a 44% decrease was observed in total during pandemic, the most significant being in April (-98%) and May (-93%). While there was a significant decrease in the number of biopsies in April (-100%) and May (-69%), it was seen that there was no decrease in the pandemic period when the whole year was looked at with a rebound increase that started with 29% in June. In the breast cancer group, there was a significant increase in the number of patients who were metastatic at the time of diagnosis compared to the pre-pandemic period (p=0.001). No significant difference was observed between the two groups in terms of tumor grade, hormone receptor status, or HER2 positivity (p>0.05). Conclusions: In this study, it was observed that both screening and diagnosis processes in breast cancer were significantly affected during the COVID-19 pandemic. It was observed that the delay in admission to the hospital in the first months of the pandemic resulted in an increase in patients who were metastatic at the time of diagnosis.

Publisher

Medical Journal of Ankara Training and Research Hospital

Subject

General Earth and Planetary Sciences,General Environmental Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3